After an ingredient used in rat poison turned up in some of its pills, SmithKline Beckman last March recalled all its Contac cold-remedy capsules (1985 sales: $55 million). The episode came soon after a Peekskill, N.Y., woman died from taking a cyanide-laced Tylenol capsule. The decision to remove Contac from the market cost SmithKline $8 million.
Now the company says that Contac will be back on the market this fall. The new capsules will have a transparent coat and will be sealed with red gelatin, which will make it more difficult for anyone to tamper with them. For those who are...
To continue reading:
or
Log-In
